Steve Gilbert is a Statistician at Pfizer in Cambridge, MA. He has worked in clinical trials since the late 1990’s, first in CROs and then in Pharma, supporting all phases of drug development in numerous therapeutic areas. Steve is a member of the Statistical Research and Innovation group, which provides statistical consulting and technical support across Pfizer. Steve’s consulting includes the risk- based monitoring, clinical statistics and quality research.
He is externally engaged with multiple PHUSE groups related to QTLs and has previously served on TransCelerate QTL efforts. Steve is a member of the ASA, ENAR and DIA; he served on the DIA missing data working group and is a member of the DIA study endpoints committee. Steve holds a PhD in statistics and a Bachelor’s in Biology.